Monica Fornier

Monica Fornier

UNVERIFIED PROFILE

Are you Monica Fornier?   Register this Author

Register author
Monica Fornier

Monica Fornier

Publications by authors named "Monica Fornier"

Are you Monica Fornier?   Register this Author

60Publications

673Reads

17Profile Views

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.

NPJ Breast Cancer 2019 29;5:26. Epub 2019 Aug 29.

"Sandro Pitigliani" Department of Medical Oncology, Prato Hospital, Via Suor Niccolina 20, Prato, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-019-0123-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715716PMC
August 2019

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.

Clin Breast Cancer 2018 10 15;18(5):387-394. Epub 2018 Mar 15.

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682312PMC
October 2018

Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

JAMA Dermatol 2018 06;154(6):670-675

Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2018.0454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145643PMC
June 2018

Less Intense Dosing Schedule for a Bone-Modifying Agent.

Authors:
Monica N Fornier

JAMA Oncol 2017 07;3(7):893-894

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6240DOI Listing
July 2017

Denosumab and fracture risk in women with breast cancer.

Lancet 2015 Nov 20;386(10008):2056-2057. Epub 2015 Nov 20.

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00973-3DOI Listing
November 2015

Limited overall survival in patients with brain metastases from triple negative breast cancer.

Breast J 2012 Jul-Aug;18(4):345-50. Epub 2012 May 21.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2012.01246.xDOI Listing
April 2013

The paradox of triple negative breast cancer: novel approaches to treatment.

Breast J 2012 Jan-Feb;18(1):41-51. Epub 2011 Nov 20.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1524-4741.2011.01175.x
Publisher Site
http://dx.doi.org/10.1111/j.1524-4741.2011.01175.xDOI Listing
September 2012

Approved agents for metastatic breast cancer.

Authors:
Monica N Fornier

Semin Oncol 2011 Jun;38 Suppl 2:S3-10

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.04.003DOI Listing
June 2011

Optimizing the use of anthracyclines in older patients with breast cancer.

Crit Rev Oncol Hematol 2011 Feb 12;77(2):131-41. Epub 2010 Mar 12.

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 475 New York NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2010.02.001DOI Listing
February 2011

Denosumab: second chapter in controlling bone metastases or a new book?

Authors:
Monica N Fornier

J Clin Oncol 2010 Dec 8;28(35):5127-31. Epub 2010 Nov 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.0128DOI Listing
December 2010

Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials.

Authors:
Monica Fornier

Clin Breast Cancer 2010 Oct;10(5):352-8

Division of Solid Tumor Oncology, Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.046DOI Listing
October 2010

Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines.

Clin Breast Cancer 2010 Sep;10 Suppl 2:S7-19

Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152682091170218
Publisher Site
http://dx.doi.org/10.3816/CBC.2010.s.008DOI Listing
September 2010

Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.

Int J Radiat Oncol Biol Phys 2010 Jul 30;77(4):1105-12. Epub 2009 Oct 30.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160900955
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2009.06.042DOI Listing
July 2010

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

Cancer Immunol Immunother 2010 Jun 6;59(6):885-97. Epub 2010 Feb 6.

Cellular Immunology Laboratory, Division of Hematology/Oncology, Department of Pediatrics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-009-0815-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268513PMC
June 2010

HER2-positive breast cancer: beyond trastuzumab.

Oncology (Williston Park) 2010 Apr;24(5):410-5

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
April 2010

A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.

J Cancer Res Clin Oncol 2009 Sep 1;135(9):1215-21. Epub 2009 Mar 1.

Integrative Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0562-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751581PMC
September 2009

NCCN Task Force Report: Bone Health in Cancer Care.

J Natl Compr Canc Netw 2009 Jun;7 Suppl 3:S1-32; quiz S33-5

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047404PMC
http://dx.doi.org/10.6004/jnccn.2009.0076DOI Listing
June 2009

Novel anti-tubulin cytotoxic agents for breast cancer.

Expert Rev Anticancer Ther 2009 Feb;9(2):175-85

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.9.2.175DOI Listing
February 2009

Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.

Clin Adv Hematol Oncol 2009 Feb;7(2):115-22

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
February 2009

Microtubule active agents: beyond the taxane frontier.

Clin Cancer Res 2008 Nov;14(22):7167-72

Memorial Sloan-Kettering Cancer Center, Breast Cancer Medicine Service, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0169DOI Listing
November 2008

Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer.

Cancer 2008 Sep;113(6):1294-301

Department of Hematology-Oncology, Penn State Hershey Cancer Center, Penn State University/Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23689DOI Listing
September 2008

Epothilones in breast cancer: current status and future directions.

Expert Rev Anticancer Ther 2008 Aug;8(8):1299-311

Department of Medical Oncology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 08001 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.8.8.129
Publisher Site
http://dx.doi.org/10.1586/14737140.8.8.1299DOI Listing
August 2008

Osteonecrosis of the jaw related to bevacizumab.

J Clin Oncol 2008 Aug;26(24):4037-8

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.5424DOI Listing
August 2008

Anabolic therapies for osteoporosis.

N Engl J Med 2007 Dec;357(23):2410-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc076405DOI Listing
December 2007

Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues.

Authors:
Monica N Fornier

Clin Breast Cancer 2007 Oct;7(10):757-63

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
October 2007

Long-term clinical outcomes of whole-breast irradiation delivered in the prone position.

Int J Radiat Oncol Biol Phys 2007 May 6;68(1):73-81. Epub 2007 Mar 6.

Department of Radiation Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.11.054DOI Listing
May 2007

Dose-dense adjuvant chemotherapy for primary breast cancer.

Breast Cancer Res 2005 10;7(2):64-9. Epub 2005 Feb 10.

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064124PMC
January 2006

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.

Cancer 2005 Oct;104(8):1575-9

Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21385DOI Listing
October 2005

Adjuvant chemotherapy for primary breast cancer.

Curr Oncol Rep 2005 Jan;7(1):18-22

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 457, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
January 2005

Risk models for neutropenia in patients with breast cancer.

Oncology (Williston Park) 2003 Nov;17(11 Suppl 11):14-20

Breast Cancer Medical Service, Memorial Sloan-Kettering, Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
November 2003

HER2 testing and correlation with efficacy of trastuzumab therapy.

Oncology (Williston Park) 2002 Oct;16(10):1340-8, 1351-2; discussion 1352, 1355-8

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
October 2002

Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review).

Int J Oncol 2002 Jun;20(6):1283-8

Operative Unit of Medical Oncology, Oncology Institute of Bari, Italy.

View Article

Download full-text PDF

Source
June 2002